|
Carotid endarterectomy (CEA) is a surgery used to treat plaque buildup (atherosclerosis) in the carotid arteries that supply oxygen-rich blood to the brain. This plaque buildup is called carotid artery disease.

Untreated, clogged carotid arteries are a major risk factor for stroke. Strokes may be caused when the arteries become completely occluded (blocked); when the plaque ruptures, causing rapid formation of a local blood clot; or when the plaque ruptures and sends pieces of debris showering down the arterial tree to become stuck in narrow arteries. This kind of stroke is known as an ischemic stroke and accounts for the majority of strokes.
CEA surgeries are meant to prevent this by debulking the carotid arteries. During a CEA, the surgeon removes the entire inner layer of the artery, stripping away the plaque that has formed along its length. As a result, the artery is widened enough to allow the free flow of blood through it.
The decision to recommend surgery is governed by the risk involved with the surgery itself versus the benefit of stroke risk reduction. CEA surgery has potentially major side effects, especially stroke during the procedure.
Because of these risks, there has been a great deal of debate among physicians about the effectiveness of CEA. It was first introduced about 45 years ago and gradually gained widespread acceptance, despite the fact that no studies had been done on its ability to prevent stroke. By the 1980s, more than 100,000 CEA surgeries were performed every year. Later studies estimated that as many as one-third of those surgeries were unnecessary. Because of this concern, the number of CEA surgeries dropped dramatically (to a low of 67,000 annually in 1991), but rebounded again to 131,000 annually in 1991.
Hoping to further refine the guidelines, in 2005, the American Academy of Neurology (AAN) Therapeutics and Technology Assessment Subcommittee analyzed data from several clinical trials and issued new guidelines to help physicians identify patients for whom CEA might help. The new guidelines include:
-
CEA was shown to reduce the risk of stroke for symptomatic patients with 70 percent to 99 percent blockage by 16 percent over five years.
-
Symptomatic patients with 50 percent to 69 percent blockage experience a 4.6 percent risk reduction over five years.
-
Patients who do not have symptoms (e.g., are asymptomatic) with 60 percent to 99 percent blockage may experience benefit, assuming that the patient is between 40 and 75 years of age, has an expected lifespan of five years, and the rates of stroke or death during surgery can be reliably documented to be less than 3 percent.
-
CEA is not recommended for patients with less than 50 percent blockage whether they have symptoms or not.
-
Patients benefit from low-dose pre- and postoperative aspirin (81 mg or 325 mg), versus high-dose regimens (650 mg or 1,300 mg).
-
Women with 50 percent to 69 percent blockage may derive little or no benefit from CEA, compared to men.
When formulating these guidelines, researchers found that if the complication rate is less than 3 percent, CEA is easier to justify. The most serious complication associated with CEA is the risk that, during the surgery, bits of plaque will shower downstream and actually cause a stroke.
This risk seems directly related to the experience of the surgeon. Less experienced surgeons report stroke rates as high as 10 percent, particularly among patients who have symptoms of stroke. By contrast, more experienced surgeons report stroke rates around 3 percent in symptomatic patients and as low as 1 percent for patients without previous symptoms of stroke.
Other research has indicated that African American men are less likely to have a carotid endarterectomy than white men. Researchers propose that physicians might not be communicating effectively with their African American patients about CEA and how it can help prevent a stroke.
Research has shown that CEA procedure can be safely performed on elderly individuals, provided they are deemed medically fit.
Obtaining a second opinion is always important when it comes to major surgery. In particular, patients who do not understand their physician, who do not feel comfortable asking their physician questions or who feel like their physician is not listening to/understanding what they have to say are encouraged to seek a second opinion. Furthermore, patients should ask specifically about a particular surgeon’s history of reducing patients’ overall risk of stroke, as well as their risk of stroke during the procedure.
As an alternative to the CEA procedure, in 2004 the Food and Drug Administration approved a less invasive method of treating carotid artery disease. Called carotid artery stenting, the procedure involves the placement of a specialized stent within the carotid arteries to keep the arteries open. Several studies have suggested that carotid artery stenting may be as effective as surgery in some cases, although CEA remains the "gold standard" to treat advanced carotid artery disease.
In general, stenting may be appropriate if a patient has had a stroke already, has a carotid artery that is at least 80 percent blocked, and is not a good candidate for surgery.
|